Exploring hypoxia-induced ncRNAs as biomarkers and therapeutic targets in lung cancer
- 5 October 2024
- journal article
- review article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 263, 155613
Abstract
No abstract availableKeywords
Funding Information
- Northern Borders University (NBU-FFR2024-2043-08)
This publication has 114 references indexed in Scilit:
- Aggregation‐Induced Emission‐Based Macrophage‐Like Nanoparticles for Targeted Photothermal Therapy and Virus Transmission Blockage in MonkeypoxAdvanced Materials, 2023
- Unwinding circular RNA’s role in inflammatory pulmonary diseasesNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Activation of Piezo1 contributes to matrix stiffness‐induced angiogenesis in hepatocellular carcinomaCancer Communications, 2022
- Exosomal mir-625-3p derived from hypoxic lung cancer cells facilitates metastasis by targeting SCAIMolecular Biology Reports, 2022
- Mechanism of WASP and WAVE family proteins in the progression of prostate cancerProtoplasma, 2021
- Recent advances in drug delivery systems for targeting cancer stem cellsActa Pharmaceutica Sinica B, 2021
- Circular RNA circPIP5K1A promotes non‐small cell lung cancer proliferation and metastasis through miR‐600/HIF‐1α regulationJournal of Cellular Biochemistry, 2019
- Inhibition of Notch and HIF enhances the antitumor effect of radiation in Notch expressing lung cancerInternational Journal of Clinical Oncology, 2016
- Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancerTumor Biology, 2015
- Hypoxic VDAC1: A Potential Mitochondrial Marker for Cancer Therapy2013